Gil Bashe Gil Bashe

Gil Bashe is Managing Partner at FINN Partners, Global Health. Gil can be reached on Twitter at @Gil_Bashe.

Think Bigger!

Historically, launching a healthcare brand has been a well-orchestrated affair. Every team prepared its ...

Can Pharma Escape the Drug Pricing Policy Hammer?

While difficult to believe that Democrats and Republicans might now find common ground on ...

A New Age in Pricing

Medicines are the preferred path to arrest disease and restore health. And while scientists ...

Say Goodbye to FDA Complacency

Too many people think the Food and Drug Administration (FDA) favors predictability over speed. ...

The Art of Indecision

Caution: We are entering a climate of uncertainty, where the natural response is a ...

From Obamacare to Trumpcare: America Readies for Change

The Affordable Care Act (ACA) has been a magnet for heated Beltway conversation since ...

Is the Consumer Still King?

Thirty years ago, medical marketing history was made with the launch of the first ...

Can the Shine be Restored to Pharma’s Tarnished Reputation Crown?

Hydro-fracturing (i.e., fracking) and tobacco have long endured societal disdain. Tolerating public abuse has ...

Reaffirmed ACA Shifts Business as Usual

Regardless of how health executives called the recent King v. Burwell coin toss, the ...